IMPROVEMENT IN CIRCULATORY AND OXYGENATION STATUS BY PERFLUBRON EMULSION (OXYGENT(TM) HT) IN A CANINE MODEL OF SURGICAL HEMODILUTION

被引:4
作者
CERNAIANU, AC [1 ]
SPENCE, RK [1 ]
VASSILIDZE, TV [1 ]
GALLUCCI, JG [1 ]
GAPRINDASHVILI, T [1 ]
OLAH, A [1 ]
WEISS, RL [1 ]
CILLEY, JH [1 ]
KEIPERT, PE [1 ]
FAITHFULL, NS [1 ]
DELROSSI, AJ [1 ]
机构
[1] ALLIANCE PHARMACEUT CORP, SAN DIEGO, CA USA
来源
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY | 1994年 / 22卷 / 04期
关键词
D O I
10.3109/10731199409138795
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To examine the effect of a low dose of Oxygent(TM) HT on hemodynamics and oxygen transport variables in a canine model of profound surgical hemodilution, two groups of adult anesthetized splenectomized beagles were hemodiluted with Ringer's solution to Hb 7 g/dL. The treated group received 1 mL/kg Oxygent(TM) HT (90% w/v perflubron emulsion [perfluorooctyl bromide], Alliance Pharmaceutical Corp.) and both groups (7 controls and 10 treated) were further hemodiluted using 6% hydroxyethyl starch until cardiorespiratory decompensation occurred. Pulmonary artery catheterization data and oxygen transport variables were recorded at Hb decrements of 1 g/dL breathing room air. There was no difference among groups during initial hemodilution. However, in the Oxygent(TM) HT group there was a statistically significant improvement in mean arterial pressure, CVP, cardiac output, PvO(2), SvO(2), DO2 and pulmonary venous admixture Shunt during profound hemodilution to Hb levels of 6, 5, and 4 g/dL. A low dose of Oxygent(TM) HT offered benefit in improving hemodynamics and oxygen transport parameters even under air breathing conditions in a model of surgical hemodilution. This effect was most apparent at lower levels of Hb.
引用
收藏
页码:965 / 977
页数:13
相关论文
共 39 条
[1]   THE MINIMUM ACCEPTABLE LEVEL OF HEMOGLOBIN [J].
ALLEN, JB ;
ALLEN, FB .
INTERNATIONAL ANESTHESIOLOGY CLINICS, 1982, 20 (04) :1-22
[2]  
BIDSTRUP BP, 1989, J THORAC CARDIOV SUR, V97, P364
[3]   SALVAGE AND REINFUSION OF POSTOPERATIVE SANGUINEOUS WOUND DRAINAGE - A PRELIMINARY-REPORT [J].
CLEMENTS, DH ;
SCULCO, TP ;
BURKE, SW ;
MAYER, K ;
LEVINE, DB .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1992, 74A (05) :646-651
[4]   TREATMENT OF SEVERE PLATELET DYSFUNCTION AND HEMORRHAGE AFTER CARDIOPULMONARY BYPASS - REDUCTION IN BLOOD PRODUCT USAGE WITH DESMOPRESSIN [J].
CZER, LSC ;
BATEMAN, TM ;
GRAY, RJ ;
RAYMOND, M ;
STEWART, ME ;
LEE, S ;
GOLDFINGER, D ;
CHAUX, A ;
MATLOFF, JM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (05) :1139-1147
[5]   FLUID RESUSCITATION OF SHOCK - CURRENT CONTROVERSIES [J].
DAWIDSON, I .
CRITICAL CARE MEDICINE, 1989, 17 (10) :1078-1080
[6]  
DELROSSI AJ, 1990, J THORAC CARDIOV SUR, V100, P281
[7]   PROPHYLACTIC TREATMENT OF POSTPERFUSION BLEEDING USING EACA [J].
DELROSSI, AJ ;
CERNAIANU, AC ;
BOTROS, S ;
LEMOLE, GM ;
MOORE, R .
CHEST, 1989, 96 (01) :27-30
[8]   ROLE OF FLUOSOL-DA 20-PERCENT IN PREHOSPITAL RESUSCITATION [J].
ELLIOTT, LA ;
LEDGERWOOD, AM ;
LUCAS, CE ;
MCCOY, LE ;
MCGONIGAL, M ;
SULLIVAN, MW .
CRITICAL CARE MEDICINE, 1989, 17 (02) :166-171
[9]   RIGHT VENTRICULAR TISSUE PO2 IN DOGS - EFFECTS OF HEMODILUTION AND ACUTE RIGHT CORONARY-ARTERY OCCLUSION [J].
FORST, H ;
RACENBERG, J ;
SCHOSSER, R ;
MESSMER, K .
RESEARCH IN EXPERIMENTAL MEDICINE, 1987, 187 (03) :159-174
[10]   EFFECTIVE MEASURES FOR REDUCING BLOOD-LOSS FROM DIAGNOSTIC LABORATORY TESTS IN INTENSIVE-CARE UNIT PATIENTS [J].
FOULKE, GE ;
HARLOW, DJ .
CRITICAL CARE MEDICINE, 1989, 17 (11) :1143-1145